Actelion
Actelion is a global, independent biopharmaceutical company discovering, developing and marketing innovative drugs for high unmet medical needs.
Actelion
|
6 FIN Sponsors
Amicus Therapeutics
Amicus Therapeutics is pioneering a paradigm-shifting approach to treating a range of human genetic diseases in which crucial proteins are misfolded, thus reducing or eliminating their functionality. Amicus develops pharmacological chaperones - oral therapies that bind to and stabilize the affected proteins, restoring their shape, proper trafficking, and biological activity. This novel, next-generation approach offers the potential to improve treatment options for patients with genetic diseases.
Amicus
|
Genzyme
Genzyme is one of the world’s leading biotechnology companies. Its more than 10,000 employees work in countries throughout the world and are united by a common goal: to make a major positive impact on the lives of people with debilitating diseases
Genzyme
|
Interaction Institute for Social Change
IISC is a non-profit organisation that |
Sanders & Clients BV
Sanders & Clients BV
is a Dutch company that deliver equipment to infuse the medicine.
